Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.8001
+0.0552 (7.41%)
At close: Jan 7, 2026, 4:00 PM EST
0.7999
-0.0002 (-0.02%)
Pre-market: Jan 8, 2026, 7:43 AM EST
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $133.22 million as of January 8, 2026. Its market cap has increased by 36.72% in one year.
Market Cap
133.22M
Enterprise Value
88.44M
1-Year Change
36.72%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $133.22M, a decrease of -77.93%. That is a compound annual growth rate of -28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 124.03M | 4.69% |
| Dec 31, 2025 | 118.47M | 4.58% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |